期刊
NATURE AGING
卷 1, 期 7, 页码 598-+出版社
SPRINGERNATURE
DOI: 10.1038/s43587-021-00082-y
关键词
-
资金
- Buck Institute for Research on Aging
- Ellison Foundation
- National Institutes of Health (NIH) [U19 AI057229, U19 AI090019]
- NIH/NCRR CTSA [UL1 RR025744]
- EU [634821]
- EU JPND ADAGE project
- Ministry of Education and Science of the Russian Federation Agreement [075-15-2020-808]
- NIH [K01 HL135455]
- Stanford TRAM scholar award
- Paul F. Glenn Foundation
- NIH Stanford Alzheimer's Disease Research Center [P50AG047366]
From analyzing the blood immunome of 1,001 individuals aged 8-96 years, researchers have developed an inflammatory clock of aging (iAge) that tracks with multimorbidity, immunosenescence, frailty, and cardiovascular aging, and is associated with exceptional longevity in centenarians. The chemokine CXCL9 plays a key role in age-related chronic inflammation and is a major contributor to iAge.
From the blood immunome of 1,001 individuals aged 8-96 years, the authors used deep learning to develop an inflammatory clock of aging (iAge) that tracks with multimorbidity, immunosenescence, frailty and cardiovascular aging, and is also associated with exceptional longevity in centenarians. The main contributor to iAge is the chemokine CXCL9, which is shown to control endothelial cell senescence and function. While many diseases of aging have been linked to the immunological system, immune metrics capable of identifying the most at-risk individuals are lacking. From the blood immunome of 1,001 individuals aged 8-96 years, we developed a deep-learning method based on patterns of systemic age-related inflammation. The resulting inflammatory clock of aging (iAge) tracked with multimorbidity, immunosenescence, frailty and cardiovascular aging, and is also associated with exceptional longevity in centenarians. The strongest contributor to iAge was the chemokine CXCL9, which was involved in cardiac aging, adverse cardiac remodeling and poor vascular function. Furthermore, aging endothelial cells in human and mice show loss of function, cellular senescence and hallmark phenotypes of arterial stiffness, all of which are reversed by silencing CXCL9. In conclusion, we identify a key role of CXCL9 in age-related chronic inflammation and derive a metric for multimorbidity that can be utilized for the early detection of age-related clinical phenotypes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据